GSK logo

GSK (GSK) Current Liabilities

GSK Annual Current Liabilities

$26.84 B
-$766.14 M-2.78%

31 December 2023

GSK Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Quarterly Current Liabilities

$28.72 B
+$2.98 B+11.60%

30 September 2024

GSK Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.8%+7.0%
3 y3 years-11.1%-10.0%
5 y5 years-6.0%-10.0%

GSK Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.0%at low-37.4%+22.7%
5 y5-year-16.0%at low-37.4%+22.7%
alltimeall time-25.3%+4745.2%-37.4%+3256.5%

GSK Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$28.72 B(+11.6%)
June 2024
-
$25.73 B(+2.7%)
Mar 2024
-
$25.06 B(-6.6%)
Dec 2023
$26.84 B(-2.8%)
$26.84 B(-1.8%)
Sept 2023
-
$27.32 B(-2.0%)
June 2023
-
$27.89 B(+8.8%)
Mar 2023
-
$25.63 B(-7.1%)
Dec 2022
$27.60 B(-13.6%)
$27.60 B(+18.0%)
Sept 2022
-
$23.40 B(-49.0%)
June 2022
-
$45.89 B(+43.9%)
Mar 2022
-
$31.89 B(-0.2%)
Dec 2021
$31.95 B(+5.8%)
$31.95 B(+6.1%)
Sept 2021
-
$30.10 B(+1.7%)
June 2021
-
$29.60 B(+6.2%)
Mar 2021
-
$27.87 B(-7.7%)
Dec 2020
$30.18 B(-4.3%)
$30.18 B(+5.8%)
Sept 2020
-
$28.53 B(-3.1%)
June 2020
-
$29.45 B(-6.0%)
Mar 2020
-
$31.34 B(-0.6%)
Dec 2019
$31.53 B(+10.5%)
$31.53 B(+0.5%)
Sept 2019
-
$31.36 B(-4.0%)
June 2019
-
$32.67 B(+2.4%)
Mar 2019
-
$31.90 B(+11.8%)
Dec 2018
$28.54 B(-20.5%)
$28.54 B(+19.1%)
Sept 2018
-
$23.97 B(+0.7%)
June 2018
-
$23.79 B(-37.0%)
Mar 2018
-
$37.74 B(+5.1%)
Dec 2017
$35.91 B(+53.8%)
$35.91 B(-2.6%)
Sept 2017
-
$36.85 B(-1.6%)
June 2017
-
$37.45 B(+60.0%)
Mar 2017
-
$23.40 B(+0.3%)
Dec 2016
$23.34 B(+17.4%)
$23.34 B(-0.7%)
Sept 2016
-
$23.51 B(-3.5%)
June 2016
-
$24.38 B(+21.9%)
Mar 2016
-
$20.00 B(+0.6%)
Dec 2015
$19.88 B(-3.9%)
$19.88 B(+2.9%)
Sept 2015
-
$19.32 B(-10.9%)
June 2015
-
$21.69 B(-7.2%)
Mar 2015
-
$23.38 B(+13.0%)
Dec 2014
$20.69 B(-8.2%)
$20.69 B(-16.6%)
Sept 2014
-
$24.80 B(+18.8%)
June 2014
-
$20.87 B(+7.5%)
Mar 2014
-
$19.42 B(-13.9%)
Dec 2013
$22.55 B(+1.0%)
$22.55 B(+8.7%)
Sept 2013
-
$20.74 B(+9.0%)
June 2013
-
$19.03 B(+4.3%)
Mar 2013
-
$18.25 B(-18.3%)
Dec 2012
$22.33 B(-3.5%)
$22.33 B(-1.5%)
Sept 2012
-
$22.66 B(-5.2%)
June 2012
-
$23.90 B(+3.1%)
Mar 2012
-
$23.19 B(+0.3%)
Dec 2011
$23.13 B(+17.1%)
$23.13 B(+13.2%)
Sept 2011
-
$20.44 B(-6.6%)
June 2011
-
$21.89 B(+3.9%)
Mar 2011
-
$21.07 B(+6.7%)
Dec 2010
$19.75 B(+0.8%)
$19.75 B(+11.2%)
Sept 2010
-
$17.76 B(-1.0%)
June 2010
-
$17.93 B(-2.8%)
Mar 2010
-
$18.45 B(-5.9%)
DateAnnualQuarterly
Dec 2009
$19.60 B(+33.6%)
$19.60 B(+10.1%)
Sept 2009
-
$17.79 B(+19.6%)
June 2009
-
$14.87 B(+6.4%)
Mar 2009
-
$13.98 B(-4.7%)
Dec 2008
$14.67 B(-28.7%)
$14.67 B(-6.4%)
Sept 2008
-
$15.67 B(-4.8%)
June 2008
-
$16.47 B(-10.5%)
Mar 2008
-
$18.41 B(-10.5%)
Dec 2007
$20.57 B(+44.6%)
$20.57 B(+11.4%)
Sept 2007
-
$18.46 B(+27.6%)
June 2007
-
$14.47 B(-1.2%)
Mar 2007
-
$14.64 B(+3.0%)
Dec 2006
$14.22 B(-13.0%)
$14.22 B(+4.2%)
Sept 2006
-
$13.65 B(-10.4%)
June 2006
-
$15.24 B(-6.1%)
Mar 2006
-
$16.24 B(-0.7%)
Dec 2005
$16.35 B(+1.4%)
$16.35 B(-1.7%)
Sept 2005
-
$16.64 B(+1.7%)
June 2005
-
$16.37 B(-5.2%)
Mar 2005
-
$17.27 B(+7.0%)
Dec 2004
$16.13 B(+5.1%)
$16.13 B(+26.9%)
Sept 2004
-
$12.71 B(-10.6%)
June 2004
-
$14.22 B(-11.3%)
Mar 2004
-
$16.04 B(+4.5%)
Dec 2003
$15.35 B(+8.1%)
$15.35 B(+10.1%)
Sept 2003
-
$13.95 B(+5.2%)
June 2003
-
$13.26 B(-0.8%)
Mar 2003
-
$13.37 B(-5.9%)
Dec 2002
$14.20 B(+3.7%)
$14.20 B(+1.2%)
Sept 2002
-
$14.03 B(-7.4%)
June 2002
-
$15.15 B(+11.9%)
Mar 2002
-
$13.54 B(-1.1%)
Dec 2001
$13.69 B(+1.1%)
$13.69 B(+2.8%)
Sept 2001
-
$13.32 B(+7.5%)
June 2001
-
$12.39 B(-9.7%)
Mar 2001
-
$13.72 B(+1.3%)
Dec 2000
$13.54 B(+59.3%)
$13.54 B(+5.5%)
Sept 2000
-
$12.83 B(-2.3%)
June 2000
-
$13.14 B(-1.2%)
Mar 2000
-
$13.30 B(+56.3%)
Dec 1999
$8.50 B(+24.1%)
$8.50 B(+19.0%)
June 1999
-
$7.15 B(+4.2%)
Dec 1998
$6.86 B(+6.5%)
$6.86 B(+16.4%)
June 1998
-
$5.89 B(-8.5%)
Dec 1997
$6.44 B(-8.8%)
$6.44 B(-8.8%)
Dec 1996
$7.06 B(-16.7%)
$7.06 B(+39.7%)
Dec 1995
$8.48 B(+67.8%)
-
June 1995
-
$5.05 B(+54.0%)
June 1995
$5.05 B(+54.0%)
-
June 1994
$3.28 B(-1.1%)
$3.28 B(-1.1%)
June 1993
$3.32 B(+11.4%)
$3.32 B(+11.4%)
June 1992
$2.98 B(-9.4%)
$2.98 B(-9.4%)
June 1991
$3.29 B(+34.2%)
$3.29 B(+34.2%)
June 1990
$2.45 B(+83.2%)
$2.45 B(+83.2%)
June 1989
$1.34 B(-9.9%)
$1.34 B(-9.9%)
June 1988
$1.48 B(+29.7%)
$1.48 B(+29.7%)
June 1987
$1.14 B(+33.8%)
$1.14 B(+33.8%)
June 1986
$855.56 M(+52.6%)
$855.56 M
June 1985
$560.59 M(+1.2%)
-
June 1984
$553.91 M
-

FAQ

  • What is GSK annual total current liabilities?
  • What is the all time high annual current liabilities for GSK?
  • What is GSK annual current liabilities year-on-year change?
  • What is GSK quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for GSK?
  • What is GSK quarterly current liabilities year-on-year change?

What is GSK annual total current liabilities?

The current annual current liabilities of GSK is $26.84 B

What is the all time high annual current liabilities for GSK?

GSK all-time high annual total current liabilities is $35.91 B

What is GSK annual current liabilities year-on-year change?

Over the past year, GSK annual total current liabilities has changed by -$766.14 M (-2.78%)

What is GSK quarterly total current liabilities?

The current quarterly current liabilities of GSK is $28.72 B

What is the all time high quarterly current liabilities for GSK?

GSK all-time high quarterly total current liabilities is $45.89 B

What is GSK quarterly current liabilities year-on-year change?

Over the past year, GSK quarterly total current liabilities has changed by +$1.88 B (+7.00%)